Impact of Apixaban on Clinical Outcome of the Patients With Large Vessel Occlusion or Stenosis Trial "ALVO"

Not yet recruiting

Phase N/A Results N/A

Summary of Purpose

The aim of this study is to investigate the clinical events of the patients with acute cerebral large vessel occlusion or stenosis and atrial fibrillation, treated by apixaban within 14 days after onset. This is the observational study that patients will be made the registration at the timing of both retrospective period and prospective period.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 27 June 2016.

1 Jul 2016 7 Jun 2016 1 May 2019 1 May 2019 1 Jun 2016 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

  • Observation: Cohort
  • Perspective: Prospective
  • Sampling: Non-Probability Sample

Contacts